日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study

原发性醛固酮增多症谱系与心血管事件风险:社区动脉粥样硬化风险研究

Lassen, Mats C H; Ostrominski, John W; Claggett, Brian L; Wijkman, Magnus O; Lee, Justin; Van't Hof, Jeremy R; Shah, Amil M; Biering-Sørensen, Tor; Solomon, Scott D; Brown, Jenifer M; Vaduganathan, Muthiah

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial

心力衰竭患者死亡方式前的生物标志物、功能状态和生活质量轨迹:FINEARTS-HF随机临床试验的事后分析

Lu, Henri; Kosztin, Annamaria; Claggett, Brian L; Foà, Alberto; Pabón, Maria A; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair D; Merkely, Bela; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; Amarante, Flaviana; Saarinen, Riitta; De Sanctis, Yoriko; Glasauer, Andrea; McMurray, John J V; Vaduganathan, Muthiah; Solomon, Scott D

Effect of Finerenone on Morbidity and Mortality in CKD

非奈利酮对慢性肾脏病患者发病率和死亡率的影响

Ostrominski, John W; Filippatos, Gerasimos; Claggett, Brian L; Miao, Zi Michael; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair; Rohwedder, Katja; Brinker, Meike D; Scalise, Andrea; Schloemer, Patrick; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Rossing, Peter; Ruilope, Luis M; Anker, Stefan D; Pitt, Bertram; Agarwal, Rajiv; McMurray, John J V; Solomon, Scott D; Vaduganathan, Muthiah

Integrating ketone bodies in multi-marker risk prediction of incident heart failure in the multi-ethnic study of atherosclerosis

在多民族动脉粥样硬化研究中,将酮体纳入多标志物风险预测中,以预测新发心力衰竭。

Chevli, Parag Anilkumar; Selvaraj, Senthil; Jaeger, Byron C; Hammoud, Aziz; Connelly, Margery A; deFilippi, Christopher; Lima, Joao A C; Khan, Sadiya S; Herrington, David M; Shapiro, Michael D; Vaduganathan, Muthiah

Finerenone and eGFR Slope across Different Levels of Baseline Albuminuria and eGFR: Insights from FINEARTS-HF

非奈利酮和eGFR斜率在不同基线白蛋白尿和eGFR水平下的变化:来自FINEARTS-HF研究的启示

Mc Causland, Finnian R; Heerspink, Hiddo J L; Vaduganathan, Muthiah; Claggett, Brian L; Desai, Akshay S; Jhund, Pardeep S; McGrath, Martina M; Rohwedder, Katja; Amarante, Flaviana; Brinker, Meike; Schloemer, Patrick; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; McMurray, John J V; Solomon, Scott D

Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trial

电子干预提高患有房颤的中青年人群流感疫苗接种率:NUDGE-FLU-CHRONIC试验的预设分析

Espersen, Caroline; Johansen, Niklas Dyrby; Vaduganathan, Muthiah; Bhatt, Ankeet S; Modin, Daniel; Skaarup, Kristoffer Grundtvig; Chatur, Safia; Claggett, Brian L; Janstrup, Kira Hyldekær; Larsen, Carsten Schade; Larsen, Lykke; Wiese, Lothar; Dalager-Pedersen, Michael; Køber, Lars; Solomon, Scott D; Sivapalan, Pradeesh; Jensen, Jens Ulrik Stæhr; Martel, Cyril Jean-Marie; Krause, Tyra Grove; Hansen, Jim; Johannessen, Arne; Marcus, Gregory M; Biering-Sørensen, Tor

Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction

射血分数轻度降低或保留的心力衰竭患者接受综合药物治疗的终身益处

Vaduganathan, Muthiah; Claggett, Brian L; Chatur, Safia; Desai, Akshay S; Jhund, Pardeep S; Vardeny, Orly; Merkely, Bela; Martinez, Felipe; Comin-Colet, Josep; Kerr Saraiva, Jose F; Shah, Sanjiv J; Lam, Carolyn S P; Zannad, Faiez; Docherty, Kieran F; McMurray, John J V; Solomon, Scott D

Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

射血分数轻度降低或保留的心力衰竭患者中,心力衰竭事件、新发糖尿病和非奈利酮之间的相互作用

Ostrominski, John W; Lu, Henri; Claggett, Brian L; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair D; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; Brinker, Meike; Schloemer, Patrick; Rohwedder, Katja; McMurray, John J V; Solomon, Scott D; Vaduganathan, Muthiah

EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF

EMPEROR 保留风险模型与 FINEARTS-HF 试验结果:FINEARTS-HF 试验的预设二次分析

Chimura, Misato; McDowell, Kirsty; Jhund, Pardeep S; Henderson, Alasdair D; Claggett, Brian L; Desai, Akshay S; Brinker, Meike; Lay-Flurrie, James; Glasauer, Andrea; Goea, Laura; Berger, Mario; Lam, Carolyn S P; Senni, Michele; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; Vaduganathan, Muthiah; Solomon, Scott D; McMurray, John J V

Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial

非奈利酮治疗射血分数轻度降低或保留的心力衰竭患者的疗效和安全性:FINEARTS-HF试验的预设分析

Docherty, Kieran F; Henderson, Alasdair D; Jhund, Pardeep S; Claggett, Brian L; Desai, Akshay S; Mueller, Katharina; Viswanathan, Prabhakar; Scalise, Andrea; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; Vaduganathan, Muthiah; Solomon, Scott D; McMurray, John J V